Event Description

New Ideas for Substance Use Condition Treatment: Could Psychedelics Help? provided an overview of psychedelic treatments, including ibogaine and psilocybin, for substance use conditions. During this panel discussion, an ibogaine researcher, a certified recovery coach with lived experience, and a drug law expert discussed existing research, potential benefits and risks, ongoing policy and legal reforms, and societal implications.

Panelists

• Moderator: Stephanie Tabashneck, PsyD, JD, Senior Fellow of Law and Applied Neuroscience, Center for Law Brain and Behavior at Harvard Medical School and Petrie-Flom Center; Licensed Psychologist; and Director, Brain InCite Neurolaw Library
• Deborah Mash, Professor of Neurology and Molecular and Cellular Pharmacology, Leonard M. Miller School of Medicine; Director, Brain Endowment Bank at the University of Miami; and Chief Executive Officer and Founder, DemeRx
• Mark Guckel, CCAR Recovery Coach Professional, EntheoRecovery Solutions, LLC
• Mason Marks, MD, JD, Visiting Professor of Law, Harvard Law School; Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center; and Florida Bar Health Law Section Professor, Florida State University College of Law

 

This event is part of the Project on Psychedelics Law and Regulation (POPLAR) and the Project on Law and Applied Neuroscience, a collaboration between the Center for Law, Brain and Behavior at Massachusetts General Hospital and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School with support from the Oswald DeN. Cammann Fund at Harvard University.